Banks Hinshaw PhD MD FACOG, a Franklin gynecologist with 30 years experience in the management of post-menopausal bone fragility (osteoporosis) and a recognized expert on treatment complications, will present a free workshop at the Macon County Public Library on Monday, Dec. 9, from 6:30 to 9 p.m.
Dr. Hinshaw was educated in chemistry at Duke University, in organic chemistry at Stanford, where he was a research fellow of the Woodrow Wilson Foundation, and in medicinal chemistry at the Ecole de Medicine et Pharmacie in Reims where he was a fellow of the National Arthritis Foundation. His medical education was at the Albany Medical College and his residency in obstetrics and gynecology was at the Albany Medical Center Hospital. He was elected a fellow of the American College of Obstetricians and Gynecologists in 1982.
Dr. Hinshaw will discuss the basic causes of increased bone fragility in women and in men and will describe the realistic strategies available for the prevention of fractures. Typical diagnostic modalities will be critically examined and explained. Current and anticipated future treatments will be covered and special attention will be paid to the available medications, including advice on avoiding the common and the less common but potentially devastating side effects of some therapies. The audience will have ample opportunity to have their personal questions answered.
This year, Dr Hinshaw contributed two papers published on the risks associated with some bone fragility therapies. He described the largest series of longitudinal cases of brittle fractures of the femur secondary to bisphosphonate medication currently available in the medical literature, following 81 patients with one or more of these fractures over an average of seven years. He presented an analysis demonstrating that the fractures and the additional complication of osteonecrosis of the jaw could have been anticipated based on the similar diseases seen in 19th century match factory workers who were exposed to the same toxin that served as the basis for the invention of the bisphosphonate drugs.